{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:36:20Z","timestamp":1789810580930,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.mehy.2017.12.018","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T03:45:11Z","timestamp":1513223111000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The role of antimalarial quality in the emergence and transmission of resistance"],"prefix":"10.1016","volume":"111","author":[{"given":"Aleisha R.","family":"Brock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua V.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-8167","authenticated-orcid":false,"given":"Adrian","family":"Esterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.12.018_b0005","series-title":"World Malaria Report 2017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.mehy.2017.12.018_b0010","series-title":"An illustrated history of malaria","author":"Poser","year":"1999"},{"key":"10.1016\/j.mehy.2017.12.018_b0015","unstructured":"Bloland PB, Williams HA. Malaria control during mass population movements and natural disasters, National Research Council. Roundtable on the Demography of Forced Migration. Committee on Population, Division of Behavioral and Social Sciences and Education and Program of Forced Migration and Health at the Mailman School of Public Health of Columbia University, Washington, DC: The National Academies Press; 2003."},{"key":"10.1016\/j.mehy.2017.12.018_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S0031182097001261","article-title":"A model for the origins and spread of drug-resistant malaria","volume":"115","author":"Hastings","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.mehy.2017.12.018_b0025","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0030141","article-title":"Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria","volume":"3","author":"O\u2019Meara","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0030","series-title":"Mechanisms of action, resistance, and new directions in drug discovery","first-page":"15","article-title":"The history of antimalarial drugs","author":"Meshnick","year":"2001"},{"key":"10.1016\/j.mehy.2017.12.018_b0035","unstructured":"Schwarte S, Ringwald P, Mendis K, Bosman A. Regulatory action needed to stop the sale of oral artemisinin-based monotherapy. In: WHO Global Malaria Programme, Editor, Essential medicines, vol. 24, no. 2, Geneva, Switzerland; 2010."},{"key":"10.1016\/j.mehy.2017.12.018_b0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cmdc.200600240","article-title":"Malaria chemotherapeutics Part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development","volume":"2","author":"Schlitzer","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.mehy.2017.12.018_b0045","unstructured":"World Health Organization and Rollback Malaria. Current status and trends of malaria. http:\/\/www.searo.who.int\/en\/Section10\/Section21\/Section338_4013.htm; 2012."},{"key":"10.1016\/j.mehy.2017.12.018_b0050","series-title":"World malaria report 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.mehy.2017.12.018_b0055","series-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.mehy.2017.12.018_b0060","unstructured":"World Health Organization, Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010, Drug Resistance and Containment Unit, Global Malaria Programme, World Health Organization, Switzerland; 2010."},{"key":"10.1016\/j.mehy.2017.12.018_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/S0891-5520(05)70400-1","article-title":"Drug resistance among malaria and other parasites","volume":"11","author":"Barat","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.mehy.2017.12.018_b0070","series-title":"Coincidence or crisis? Prescription medicine counterfeiting","author":"Harper","year":"2006"},{"key":"10.1016\/j.mehy.2017.12.018_b0075","unstructured":"World Health Organization, WHO expert committee on specifications for pharmaceutical preparations WHO technical report series; no. 957, Switzerland; 2010."},{"key":"10.1016\/j.mehy.2017.12.018_b0080","unstructured":"World Health Organization, Joint FIP\/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, No. 961 (2011). <http:\/\/apps.who.int\/medicinedocs\/documents\/s18676en\/s18676en.pdf>."},{"key":"10.1016\/j.mehy.2017.12.018_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1357-8","article-title":"Combating poor quality antimalarial medicines: a call to action","volume":"15","author":"Bassat","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050032","article-title":"A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia","volume":"5","author":"Newton","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake antimalarials: start with the facts","volume":"15","author":"Kaur","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(06)70581-3","article-title":"Counterfeit anti-infective drugs","volume":"6","author":"Newton","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mehy.2017.12.018_b0105","unstructured":"World Health Organization,Seventieth World Health Assembly update, 29 May 2017, http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/dementia-immunization-refuguees\/en\/; 2017 (accessed 8 November 2017)."},{"key":"10.1016\/j.mehy.2017.12.018_b0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14787210.2016.1187560","article-title":"A link between poor quality antimalarials and malaria drug resistance?","volume":"14","author":"Newton","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.mehy.2017.12.018_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020100","article-title":"The global threat of counterfeit drugs: why industry and governments must communicate the dangers","volume":"2","author":"Cockburn","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","article-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","volume":"12","author":"Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mehy.2017.12.018_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-139","article-title":"Mind the gaps \u2013 the epidemiology of poor-quality anti-malarials in the malarious world \u2013 analysis of the WorldWide Antimalarial Resistance Network database","volume":"13","author":"Tabernero","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-10-352","article-title":"Poor quality vital anti-malarials in Africa \u2013 an urgent neglected public health priority","volume":"10","author":"Newton","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0135","doi-asserted-by":"crossref","first-page":"e1000887","DOI":"10.1371\/journal.ppat.1000887","article-title":"Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum","volume":"6","author":"Valderramos","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mehy.2017.12.018_b0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2017.12.018_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-3-2","article-title":"Can mutation and selection explain virulence in human P. falciparum infections?","volume":"3","author":"Hastings","year":"2004","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0150","first-page":"2952","article-title":"Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites","volume":"64","author":"Huijben","year":"2010","journal-title":"Evolution"},{"key":"10.1016\/j.mehy.2017.12.018_b0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1752-4571.2008.00067.x","article-title":"Probability of emergence of antimalarial resistance in different stages of the parasite life cycle","volume":"2","author":"Pongtavornpinyo","year":"2009","journal-title":"Evol Appl"},{"key":"10.1016\/j.mehy.2017.12.018_b0160","series-title":"Molecular epidemiology of infectious diseases","first-page":"93","article-title":"Malaria","author":"Walliker","year":"2000"},{"key":"10.1016\/j.mehy.2017.12.018_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-8-253","article-title":"Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance","volume":"8","author":"White","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003578","article-title":"Aggressive chemotherapy and the selection of drug resistant pathogens","volume":"9","author":"Huijben","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mehy.2017.12.018_b0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/dkl158","article-title":"Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine","volume":"58","author":"Gatton","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mehy.2017.12.018_b0180","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1098\/rspb.2010.1907","article-title":"Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria","volume":"278","author":"Antao","year":"2011","journal-title":"Proc R Soc B"},{"key":"10.1016\/j.mehy.2017.12.018_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-2-3","article-title":"Epidemiological models for the spread of anti-malarial resistance","volume":"2","author":"Koella","year":"2003","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1475-2875-9-190","article-title":"Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine\/pyrimethamine","volume":"9","author":"Malisa","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0169-4758(88)90042-7","article-title":"Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?","volume":"4","author":"Payne","year":"1988","journal-title":"Parasitol Today"},{"key":"10.1016\/j.mehy.2017.12.018_b0200","series-title":"Antimicrobial resistance in developing countries","article-title":"Counterfeit and substandard anti-infectives in developing countries","author":"Newton","year":"2010"},{"key":"10.1016\/j.mehy.2017.12.018_b0205","doi-asserted-by":"crossref","first-page":"e1000403","DOI":"10.1371\/journal.pmed.1000403","article-title":"Research agenda for malaria eradication: modeling","volume":"8","author":"The malERA Consultative Group on Modeling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30269-9","article-title":"Does antimalarial mass drug administration increase or decrease the risk of resistance?","volume":"17","author":"White","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mehy.2017.12.018_b0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3934\/mbe.2005.2.227","article-title":"A reaction-diffusion system modeling the spread of resistance to an antimalarial drug","volume":"2","author":"Bacaer","year":"2005","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.mehy.2017.12.018_b0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tpb.2008.10.002","article-title":"Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas","volume":"75","author":"Chiyaka","year":"2009","journal-title":"Theor Popul Biol"},{"key":"10.1016\/j.mehy.2017.12.018_b0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.actatropica.2005.04.003","article-title":"Intensity of malaria transmission and the evolution of drug resistance","volume":"94","author":"Hastings","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.mehy.2017.12.018_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-7-67","article-title":"Clinically immune hosts as a refuge for drug-sensitive malaria parasites","volume":"7","author":"Klein","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0235","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-6-9","article-title":"Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance","volume":"6","author":"Alexander","year":"2007","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0240","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1098\/rspb.2002.2241","article-title":"The de novo selection of drug-resistant malaria parasites","volume":"270","author":"White","year":"2003","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.mehy.2017.12.018_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-7-229","article-title":"Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies","volume":"7","author":"Pongtavornpinyo","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0250","first-page":"1","article-title":"Antibiotic and antimalarial selfmedication in Antananarivo, Madagascar","volume":"1","author":"Sendrasoa","year":"2016","journal-title":"Int J Infect Dis Ther"},{"key":"10.1016\/j.mehy.2017.12.018_b0255","article-title":"High school students are a target group for fight against self-medication with antimalarial drugs: a pilot study in University of Kinshasa, Democratic Republic of Congo","author":"Kamitalu","year":"2016","journal-title":"J Trop Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pt.2007.11.008","article-title":"Antimalarial dosing regimens and drug resistance","volume":"24","author":"Barnes","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mehy.2017.12.018_b0265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1475-2875-13-62","article-title":"Pharmacological considerations in the design of anti-malarial drug combination therapies \u2013 is matching half-lives enough?","volume":"13","author":"Hastings","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00285-013-0716-0","article-title":"A quantitative model of population dynamics in malaria with drug treatment","volume":"69","author":"An","year":"2014","journal-title":"J Math Biol"},{"key":"10.1016\/j.mehy.2017.12.018_b0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4269\/ajtmh.2005.72.163","article-title":"The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations","volume":"72","author":"Watkins","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mehy.2017.12.018_b0280","doi-asserted-by":"crossref","DOI":"10.3201\/eid1511.090886","article-title":"Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003","volume":"15","author":"Leslie","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mehy.2017.12.018_b0285","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/AAC.47.9.2929-2932.2003","article-title":"Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing","volume":"47","author":"Terlouw","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2017.12.018_b0290","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.clpt.2006.08.016","article-title":"Sulfadoxine-pyrimethamine pharmacokinetics in malaria: Pediatric dosing implications","volume":"80","author":"Barnes","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2017.12.018_b0295","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(95)92620-8","article-title":"Quality of antimalarial drugs and resistance to Plasmodium vivax in Amazonian region","volume":"345","author":"Petralanda","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2017.12.018_b0300","article-title":"Manslaughter by fake artesunate in Asia\u2014Will Africa be next?","volume":"3","author":"Newton","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2017.12.018_b0305","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1365-3156.2004.01342.x","article-title":"Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials","volume":"9","author":"Dondorp","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.mehy.2017.12.018_b0310","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(95)92145-1","article-title":"Drug quality, a contributor to drug resistance?","volume":"346","author":"Taylor","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2017.12.018_b0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1475-2875-13-209","article-title":"The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence","volume":"13","author":"Karunamoorthi","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.mehy.2017.12.018_b0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.14-0725","article-title":"Estimated under-five deaths associated with poor-quality antimalarials in Sub-Saharan Africa","volume":"92","author":"Renschler","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mehy.2017.12.018_b0325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0001-706X(94)90060-4","article-title":"Epidemiology of drug resistance in malaria","volume":"56","author":"Wernsdorfer","year":"1994","journal-title":"Acta Trop"},{"key":"10.1016\/j.mehy.2017.12.018_b0330","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","article-title":"Chloroquine resistance in Plasmodium vivax","volume":"48","author":"Baird","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730926X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730926X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:45:26Z","timestamp":1570481126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771730926X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"alternative-id":["S030698771730926X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.12.018","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of antimalarial quality in the emergence and transmission of resistance","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}